The 'Dispatched' Week in Review Podcast - 4 October

This is a preview of subscriber content

Subscribe now to continue reading.

A significant structural change in the PBS, which the Government attempted to blunt with 60-day dispensed quantities, is arguably the main growth driver in spending on the program. We discuss the change, which along with others, represents a major reversal in a decades-long approach to medicines access. …

Subscribe now to continue reading.

The 'Dispatched' Week in Review Podcast - 4 October

This is a preview of subscriber content

Latest Video

Most Read

Across-the-board PBS levy would simply be a tax on the listing and pricing process

Priceline Pharmacy launches annual event with national menopause project

Pharmacy Guild says Healthscope collapse provides 'stark warning'

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

For patients, it's about understanding their experience and accessing the touchpoints

New Stories

Dimerix says first ACTION3 trial site activated in Japan and first milestone payment triggered

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

TGA approves new therapy for children with growth hormone deficiency

AbbVie Australia appoints Dr Carly Levetan associate medical director

For patients, it's about understanding their experience and accessing the touchpoints

Priceline Pharmacy launches annual event with national menopause project

Anne Ruston welcomes her reappointment to health and the addition of NDIS

Sign In

The 'Dispatched' Week in Review Podcast - 4 October

This is a preview of subscriber content

Latest Video

Most Read

Across-the-board PBS levy would simply be a tax on the listing and pricing process

Priceline Pharmacy launches annual event with national menopause project

Pharmacy Guild says Healthscope collapse provides 'stark warning'

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

For patients, it's about understanding their experience and accessing the touchpoints

Follow Us

New Stories

Dimerix says first ACTION3 trial site activated in Japan and first milestone payment triggered

Arrotex Pharmaceuticals appointed exclusive partner for Juniper Biologics

TGA approves new therapy for children with growth hormone deficiency

AbbVie Australia appoints Dr Carly Levetan associate medical director

For patients, it's about understanding their experience and accessing the touchpoints

Priceline Pharmacy launches annual event with national menopause project

Anne Ruston welcomes her reappointment to health and the addition of NDIS